Global Medical Alpha Radionuclide Market Research Report 2026(Status and Outlook)
Description
Report Overview
Targeted alpha-particle therapy (or TAT) is an in-development method of targeted radionuclide therapy of various cancers. It employs radioactive substances which undergo alpha decay to treat diseased tissue at close proximity. It has the potential to provide highly targeted treatment, especially to microscopic tumour cells. Targets include leukemias, lymphomas, gliomas, melanoma, and peritoneal carcinomatosis. As in diagnostic nuclear medicine, appropriate radionuclides can be chemically bound to a targeting biomolecule which carries the combined radiopharmaceutical to a specific treatment point.
The global Medical Alpha Radionuclide market size was estimated at USD 3544.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 14.60% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Medical Alpha Radionuclide market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Medical Alpha Radionuclide market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Medical Alpha Radionuclide market.
Global Medical Alpha Radionuclide Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
ORNL
Tri-Lab
SSC RF-IPPE
JRC Karlsruhe
TerraPower
TRIUMF
Eckert&Ziegler
Ionetix
Orano Med
National Nuclear Laboratory
NorthStar
Market Segmentation (by Type)
Actinium-225
Astatine-211
Lead-212
Bismuth-213
Others
Market Segmentation (by Application)
Immunotherapy
Peritoneal Carcinomas
Bone Metastases
Leukaemia
Melanomas
Solid Tumours
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Medical Alpha Radionuclide Market
Overview of the regional outlook of the Medical Alpha Radionuclide Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Medical Alpha Radionuclide Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Medical Alpha Radionuclide, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Targeted alpha-particle therapy (or TAT) is an in-development method of targeted radionuclide therapy of various cancers. It employs radioactive substances which undergo alpha decay to treat diseased tissue at close proximity. It has the potential to provide highly targeted treatment, especially to microscopic tumour cells. Targets include leukemias, lymphomas, gliomas, melanoma, and peritoneal carcinomatosis. As in diagnostic nuclear medicine, appropriate radionuclides can be chemically bound to a targeting biomolecule which carries the combined radiopharmaceutical to a specific treatment point.
The global Medical Alpha Radionuclide market size was estimated at USD 3544.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 14.60% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Medical Alpha Radionuclide market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Medical Alpha Radionuclide market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Medical Alpha Radionuclide market.
Global Medical Alpha Radionuclide Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
ORNL
Tri-Lab
SSC RF-IPPE
JRC Karlsruhe
TerraPower
TRIUMF
Eckert&Ziegler
Ionetix
Orano Med
National Nuclear Laboratory
NorthStar
Market Segmentation (by Type)
Actinium-225
Astatine-211
Lead-212
Bismuth-213
Others
Market Segmentation (by Application)
Immunotherapy
Peritoneal Carcinomas
Bone Metastases
Leukaemia
Melanomas
Solid Tumours
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Medical Alpha Radionuclide Market
Overview of the regional outlook of the Medical Alpha Radionuclide Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Medical Alpha Radionuclide Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Medical Alpha Radionuclide, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Table of Contents
142 Pages
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Medical Alpha Radionuclide
- 1.2 Key Market Segments
- 1.2.1 Medical Alpha Radionuclide Segment by Type
- 1.2.2 Medical Alpha Radionuclide Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Medical Alpha Radionuclide Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Medical Alpha Radionuclide Market Size (M USD) Estimates and Forecasts (2020-2035)
- 2.1.2 Global Medical Alpha Radionuclide Sales Estimates and Forecasts (2020-2035)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Medical Alpha Radionuclide Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Medical Alpha Radionuclide Product Life Cycle
- 3.3 Global Medical Alpha Radionuclide Sales by Manufacturers (2020-2025)
- 3.4 Global Medical Alpha Radionuclide Revenue Market Share by Manufacturers (2020-2025)
- 3.5 Medical Alpha Radionuclide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.6 Global Medical Alpha Radionuclide Average Price by Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
- 3.8 Medical Alpha Radionuclide Market Competitive Situation and Trends
- 3.8.1 Medical Alpha Radionuclide Market Concentration Rate
- 3.8.2 Global 5 and 10 Largest Medical Alpha Radionuclide Players Market Share by Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Medical Alpha Radionuclide Industry Chain Analysis
- 4.1 Medical Alpha Radionuclide Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Medical Alpha Radionuclide Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 PEST Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Medical Alpha Radionuclide Market Porter's Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions and Their Impacts to Medical Alpha Radionuclide Market
- 5.7 ESG Ratings of Leading Companies
- 6 Medical Alpha Radionuclide Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Medical Alpha Radionuclide Sales Market Share by Type (2020-2025)
- 6.3 Global Medical Alpha Radionuclide Market Size by Type (2020-2025)
- 6.4 Global Medical Alpha Radionuclide Price by Type (2020-2025)
- 7 Medical Alpha Radionuclide Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Medical Alpha Radionuclide Market Sales by Application (2020-2025)
- 7.3 Global Medical Alpha Radionuclide Market Size (M USD) by Application (2020-2025)
- 7.4 Global Medical Alpha Radionuclide Sales Growth Rate by Application (2020-2025)
- 8 Medical Alpha Radionuclide Market Sales by Region
- 8.1 Global Medical Alpha Radionuclide Sales by Region
- 8.1.1 Global Medical Alpha Radionuclide Sales by Region
- 8.1.2 Global Medical Alpha Radionuclide Sales Market Share by Region
- 8.2 Global Medical Alpha Radionuclide Market Size by Region
- 8.2.1 Global Medical Alpha Radionuclide Market Size by Region
- 8.2.2 Global Medical Alpha Radionuclide Market Size by Region
- 8.3 North America
- 8.3.1 North America Medical Alpha Radionuclide Sales by Country
- 8.3.2 North America Medical Alpha Radionuclide Market Size by Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Medical Alpha Radionuclide Sales by Country
- 8.4.2 Europe Medical Alpha Radionuclide Market Size by Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Medical Alpha Radionuclide Sales by Region
- 8.5.2 Asia Pacific Medical Alpha Radionuclide Market Size by Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Medical Alpha Radionuclide Sales by Country
- 8.6.2 South America Medical Alpha Radionuclide Market Size by Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East and Africa
- 8.7.1 Middle East and Africa Medical Alpha Radionuclide Sales by Region
- 8.7.2 Middle East and Africa Medical Alpha Radionuclide Market Size by Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 UAE Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 9 Medical Alpha Radionuclide Market Production by Region
- 9.1 Global Production of Medical Alpha Radionuclide by Region(2020-2025)
- 9.2 Global Medical Alpha Radionuclide Revenue Market Share by Region (2020-2025)
- 9.3 Global Medical Alpha Radionuclide Production, Revenue, Price and Gross Margin (2020-2025)
- 9.4 North America Medical Alpha Radionuclide Production
- 9.4.1 North America Medical Alpha Radionuclide Production Growth Rate (2020-2025)
- 9.4.2 North America Medical Alpha Radionuclide Production, Revenue, Price and Gross Margin (2020-2025)
- 9.5 Europe Medical Alpha Radionuclide Production
- 9.5.1 Europe Medical Alpha Radionuclide Production Growth Rate (2020-2025)
- 9.5.2 Europe Medical Alpha Radionuclide Production, Revenue, Price and Gross Margin (2020-2025)
- 9.6 Japan Medical Alpha Radionuclide Production (2020-2025)
- 9.6.1 Japan Medical Alpha Radionuclide Production Growth Rate (2020-2025)
- 9.6.2 Japan Medical Alpha Radionuclide Production, Revenue, Price and Gross Margin (2020-2025)
- 9.7 China Medical Alpha Radionuclide Production (2020-2025)
- 9.7.1 China Medical Alpha Radionuclide Production Growth Rate (2020-2025)
- 9.7.2 China Medical Alpha Radionuclide Production, Revenue, Price and Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 ORNL
- 10.1.1 ORNL Basic Information
- 10.1.2 ORNL Medical Alpha Radionuclide Product Overview
- 10.1.3 ORNL Medical Alpha Radionuclide Product Market Performance
- 10.1.4 ORNL Business Overview
- 10.1.5 ORNL SWOT Analysis
- 10.1.6 ORNL Recent Developments
- 10.2 Tri-Lab
- 10.2.1 Tri-Lab Basic Information
- 10.2.2 Tri-Lab Medical Alpha Radionuclide Product Overview
- 10.2.3 Tri-Lab Medical Alpha Radionuclide Product Market Performance
- 10.2.4 Tri-Lab Business Overview
- 10.2.5 Tri-Lab SWOT Analysis
- 10.2.6 Tri-Lab Recent Developments
- 10.3 SSC RF-IPPE
- 10.3.1 SSC RF-IPPE Basic Information
- 10.3.2 SSC RF-IPPE Medical Alpha Radionuclide Product Overview
- 10.3.3 SSC RF-IPPE Medical Alpha Radionuclide Product Market Performance
- 10.3.4 SSC RF-IPPE Business Overview
- 10.3.5 SSC RF-IPPE SWOT Analysis
- 10.3.6 SSC RF-IPPE Recent Developments
- 10.4 JRC Karlsruhe
- 10.4.1 JRC Karlsruhe Basic Information
- 10.4.2 JRC Karlsruhe Medical Alpha Radionuclide Product Overview
- 10.4.3 JRC Karlsruhe Medical Alpha Radionuclide Product Market Performance
- 10.4.4 JRC Karlsruhe Business Overview
- 10.4.5 JRC Karlsruhe Recent Developments
- 10.5 TerraPower
- 10.5.1 TerraPower Basic Information
- 10.5.2 TerraPower Medical Alpha Radionuclide Product Overview
- 10.5.3 TerraPower Medical Alpha Radionuclide Product Market Performance
- 10.5.4 TerraPower Business Overview
- 10.5.5 TerraPower Recent Developments
- 10.6 TRIUMF
- 10.6.1 TRIUMF Basic Information
- 10.6.2 TRIUMF Medical Alpha Radionuclide Product Overview
- 10.6.3 TRIUMF Medical Alpha Radionuclide Product Market Performance
- 10.6.4 TRIUMF Business Overview
- 10.6.5 TRIUMF Recent Developments
- 10.7 EckertandZiegler
- 10.7.1 EckertandZiegler Basic Information
- 10.7.2 EckertandZiegler Medical Alpha Radionuclide Product Overview
- 10.7.3 EckertandZiegler Medical Alpha Radionuclide Product Market Performance
- 10.7.4 EckertandZiegler Business Overview
- 10.7.5 EckertandZiegler Recent Developments
- 10.8 Ionetix
- 10.8.1 Ionetix Basic Information
- 10.8.2 Ionetix Medical Alpha Radionuclide Product Overview
- 10.8.3 Ionetix Medical Alpha Radionuclide Product Market Performance
- 10.8.4 Ionetix Business Overview
- 10.8.5 Ionetix Recent Developments
- 10.9 Orano Med
- 10.9.1 Orano Med Basic Information
- 10.9.2 Orano Med Medical Alpha Radionuclide Product Overview
- 10.9.3 Orano Med Medical Alpha Radionuclide Product Market Performance
- 10.9.4 Orano Med Business Overview
- 10.9.5 Orano Med Recent Developments
- 10.10 National Nuclear Laboratory
- 10.10.1 National Nuclear Laboratory Basic Information
- 10.10.2 National Nuclear Laboratory Medical Alpha Radionuclide Product Overview
- 10.10.3 National Nuclear Laboratory Medical Alpha Radionuclide Product Market Performance
- 10.10.4 National Nuclear Laboratory Business Overview
- 10.10.5 National Nuclear Laboratory Recent Developments
- 10.11 NorthStar
- 10.11.1 NorthStar Basic Information
- 10.11.2 NorthStar Medical Alpha Radionuclide Product Overview
- 10.11.3 NorthStar Medical Alpha Radionuclide Product Market Performance
- 10.11.4 NorthStar Business Overview
- 10.11.5 NorthStar Recent Developments
- 11 Medical Alpha Radionuclide Market Forecast by Region
- 11.1 Global Medical Alpha Radionuclide Market Size Forecast
- 11.2 Global Medical Alpha Radionuclide Market Forecast by Region
- 11.2.1 North America Market Size Forecast by Country
- 11.2.2 Europe Medical Alpha Radionuclide Market Size Forecast by Country
- 11.2.3 Asia Pacific Medical Alpha Radionuclide Market Size Forecast by Region
- 11.2.4 South America Medical Alpha Radionuclide Market Size Forecast by Country
- 11.2.5 Middle East and Africa Forecasted Sales of Medical Alpha Radionuclide by Country
- 12 Forecast Market by Type and by Application (2026-2035)
- 12.1 Global Medical Alpha Radionuclide Market Forecast by Type (2026-2035)
- 12.1.1 Global Forecasted Sales of Medical Alpha Radionuclide by Type (2026-2035)
- 12.1.2 Global Medical Alpha Radionuclide Market Size Forecast by Type (2026-2035)
- 12.1.3 Global Forecasted Price of Medical Alpha Radionuclide by Type (2026-2035)
- 12.2 Global Medical Alpha Radionuclide Market Forecast by Application (2026-2035)
- 12.2.1 Global Medical Alpha Radionuclide Sales (K MT) Forecast by Application
- 12.2.2 Global Medical Alpha Radionuclide Market Size (M USD) Forecast by Application (2026-2035)
- 13 Conclusion and Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
